Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

33%

2 trials in Phase 3/4

Results Transparency

0 of 1 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A

3(60.0%)

Phase 3

2(40.0%)

5Total

N/A(3)

Phase 3(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT06887881Not ApplicableRecruiting

PIMS vs PGT-A in Infertile PCOS Patients

Role: collaborator

NCT07065539Not ApplicableNot Yet Recruiting

GnRH Agonist Pretreatment Duration and Letrozole Supplementation in Frozen Embryo Transfer for Adenomyosis Patients

Role: collaborator

NCT06767722Not ApplicableRecruiting

Effectiveness of a Lifestyle Intervention for Pregnant Women With Abnormal Glucose Metabolism in Early Pregnancy: EAGM Trial

Role: collaborator

NCT05811676Phase 3Completed

Tranexamic Acid for the Prevention of Postpartum Hemorrhage in Pregnant Women With Placenta Previa

Role: collaborator

NCT04440670Phase 3Unknown

Effect of Autologous Cord Blood Mononuclear Cells for Prevention of Bronchopulmonary Dysplasia or Death in Extremely Preterm Neonates

Role: collaborator

NCT04113070Recruiting

Overweight and Obesity and Puberty Development Cohort Study

Role: collaborator

All 6 trials loaded